Search

everythinglearnresearchcommunity

for

Search:↓

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Too much prolactin can cause menstrual problems, infertility, and sexual issues in women.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

New treatments for male hypogonadism are effective and should be personalized.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Moderately high prolactin levels do not cause hair loss in women.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Healthcare providers need better education and policies to serve transgender individuals effectively.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Some patients with high prolactin levels don't show symptoms because they have a form of the hormone that's less active.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Aging men face unique health issues like erectile dysfunction, prostate problems, and baldness.